Duke-FDA Coalition Names C3 Board Chair to Clinical Trial Initiative

Posted by Michael Sola on May 12th, 2008

The Clinical Trials Transformation Initiative (CTTI), a growing, broad-based coalition of organizations dedicated to modernizing the way clinical trials are conducted in the United States, has named a 12-member Executive Board that will oversee its activities.

Founded by the U.S. Food and Drug Administration (FDA) and Duke University as a public-private partnership, CTTI seeks to improve the quality and efficiency of clinical trials. CTTI was formed in the wake of growing frustration among patients, consumers, the academic community and industry over the difficulty of conducting high-quality clinical trials in a timely manner that could produce information physicians need to define optimal treatments for their patients.

This board comprises leading figures in government, academia, industry (pharmaceutical, biotechnology, device and contract research) and patient advocacy.

C3 Board Chair Nancy Roach has been named a member of the CTTI Executive Board as the only representative of the patient advocacy community.

Comments (1): Add a comment

One Response to “Duke-FDA Coalition Names C3 Board Chair to Clinical Trial Initiative”

May 28, 2008 at 5:05 pm, Jo-Ellen said:

Who is more able than Nancy to take on this important responsibility? Thank you, Nancy, for continuing to fill your plate–we need your energy!

Your comments are welcome. However, specific medical advice will not be provided. Generic QUESTIONS can be directed to our Answer Line team at http://fightcolorectalcancer.org/awareness/answer-line or by calling us at 1-877-427-2111 9:00 AM – 5:00 PM Eastern time, Monday – Friday. We urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. Fight Colorectal Cancer is not responsible for the medical accuracy of any comments left by persons other than Fight Colorectal Cancer staff members. Fight Colorectal Cancer staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment.